Abstract: Since December 2019,the number of corona virus disease 2019 cases has continued to increase.With the spread of the epidemic,clinical trials of anticancer drugs are facing great challenge.Cancer patients are suffering from the tumor itself,surgery,radiotherapy and chemotherapy under special immune status,they are susceptible to the new coronavirus,and are more susceptible to infection with the coronavirus than the normal population.Therefore,this article will elaborate on the particularity of subjects in clinical trials of anticancer drugs in the context of the corona virus disease 2019,management of clinical trials,existing problems and countermeasures to expect optimizing processes and reasonable arrangements,and to ensure the safety of patients so that the smooth progress of the clinical trial is guaranteed.

Key words: Corona virus disease 2019(COVID-19), Anticancer drug clinical trials, Management